Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid.
about
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation.Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor.
P2860
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@en
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@nl
type
label
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@en
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@nl
prefLabel
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@en
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@nl
P2093
P2860
P1476
Intestinal solubilization, abs ...... lity of chenodeoxycholic acid.
@en
P2093
Dowling RH
Ponz de Leon M
P2860
P304
P356
10.1111/J.1365-2362.1980.TB00032.X
P577
1980-08-01T00:00:00Z